| Summary: | Thyroid orbitopathy is an inflammatory and autoimmune disease of the orbital and periorbital tissues that characterized as developing autoantibodies against thyroid stimulating hormone receptor (TSH-R). The most important clinical manifestations of thyroid orbitopathy are soft tissue involvement, eyelid retraction, proptosis, optic neuropathy, and restrictive myopathy.
Prostaglandin analogs (latanoprost, bimatoprost, travoprost, and unoproston) are used to reduce intraocular pressure in people who have glaucoma or ocular hypertension. The most important side efffects of prostaglandin analogs are change of iris color, growth of eyelashes, conjunctival hyperemia, and chemosis.
In this study, it is aimed to report a patient using a prostaglandin analog drop presenting with redness and chemosis of the conjunctiva that may be misdiagnosed as increased clinical activity score in thyroid orbitopathy disease.
|
|---|